Veronica L. Hall

Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH.

Redpath Partners, Inc. provides complex cancer diagnostic testing for pathologists, oncologists and clinicians. The company was founded by Del Mary Brady and Sydney D. Finkelstein and is headquartered in Pittsburgh, PA.

Cayenne Medical, Inc. operates as a sports medicine device company which specializes in the soft tissue reconstruction segments. It focuses on the transformation of traditional arthroscopic procedures, by applying advanced technology through minimally invasive techniques. The firm also provides Quattro systems which are knotless and pre-loaded suture anchors and tailored instrumentations. The company was founded by Ed L. Chang, James W. Hart and Heber C. Crockett in March 2005 and is headquartered in Scottsdale, AZ.

BioMotiv LLC operates as a research institution in the field of therapeutics. It focuses in disease areas and classes of therapeutics such as small molecules, antibodies, proteins, and nucleotides. The company was founded on September 10, 2012 and is headquartered in Cleveland, OH.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA.

Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation.

Fletcher Spaght Venture Partners LLC (Fletcher Spaght Ventures) is a venture capital subsidiary of Fletcher Spaght Inc founded in 2000 by R John Fletcher Fletcher. The firm is headquartered in Boston, Massachusetts.

Vytal, Inc. provides medication access, adherence, and direct-to-patient consumer programs. It offers prescription assistance, patient engagement, anticipatory logistic solutions, and omni-channel platform. The company was founded Levin Scott Bechtler, Paul Cattaneo, and Robert J. Feeney Jr. in 2000 and is headquartered in San Diego, CA.

Coral Group, Inc. is a venture capital firm. It offers telecom, Internet and media content, real time data, IoT sectors, mobile, security, ecommerce, and cloud services. The company was founded by Yuval Almog in 1990 and is headquarterd in Minneapolis, MN.

CID Capital Ventures (CID Capital Ventures) is a venture capital subsidiary of CID Capital Inc founded in 1981. CID Capital Ventures is Headquartered in Indianapolis, Indiana.

Juventas Therapeutics, Inc. provides regenerative therapies for cardiovascular disease. It is a clinical-stage biotechnology company developing a pipeline of factor-based regenerative therapies to treat life-threatening diseases. The company's product has been shown to protect and repair tissue following ischemic injury by recruiting the body's own stem cells to the damaged tissue. The company was founded by Rahul A. Aras and Marc S. Penn in 2007 and is headquartered in Cleveland, OH.

Reference Capital Management LLC (Reference Capital) is a venture capital firm founded in 2006 by Wayne L. Embree and Brock Metcalf. The firm is headquartered in Portland, Oregon.

The Cleveland Clinic Foundation operates as a non-profit academic, research, and medical center. It offers clinic and hospital care with research and education services. The company was founded by Charles Posternack, George W. Crile, Frank E. Bunts, William E. Lower and John Phillips on February,5 1921 and is headquartered in Cleveland, OH.

Airway Therapeutics, Inc. operates as a pharmaceutical company which specializes in the development of surfactant-related products. The firm offers products for the prevention of bronchopulmonary dysplasia, as well as for the treatment of pulmonary infections associated with cystic fibrosis. It also provides pediatric drug development, orphan drug development, pulmonary therapies, protein drug development, neonatal drug therapy, and inhalation drug delivery. The company was founded by Charles McOsker in 2011 and is headquartered in Cincinnati, OH.

Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC.

Yamo Pharmaceuticals LLC is a clinical stage pharmaceutical company that was founded in 2015. Yamo Pharmaceuticals is a privately held company and is based in New York, NY. The company's focus is on developing L1-79, a novel therapy that has the potential to improve the core symptoms of ASD. The CEO of the company is Charles J. Bramlage.

Part of Innoviva, Inc., La Jolla Pharmaceutical II BV provides healthcare services. The company is based in Amsterdam, Netherlands.

Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections.

Part of Santo Holding (Deutschland) GmbH, Aicuris Anti-Infective Cures AG aims to discover, develop, and deliver innovative, anti-viral drugs to immunocompromised patients aiming to prevent severe condition and life-threatening diseases. The company is based in Wuppertal, Germany. Aicuris has developed a commercial drug as well as pipeline of clinical-stage and pre-clinical anti-viral candidates. Its lead product Prevymis® (letermovir), a first-in-class non-nucleoside cytomegalovirus (CMV) inhibitor, was licensed to MSD and is commercialized for the prevention of human CMV infections in immunocompromised patients who underwent an allogeneic hematopoietic stem cell transplantation or kidney transplantation. Aicuris wholly owned product candidate, Pritelivir, targeting resistant herpes simplex virus (HSV) infections in immunocompromised patients, is in phase 3 clinical development. The German company was founded in 2006 by Helga Rübsamen-Schaeff. Larry G. Edwards has been the CEO of the company since 2023.

Part of Innoviva, Inc., La Jolla Pharma LLC is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Dover, DE.

TechLink is a non-profit organization that assists companies and entrepreneurs in evaluating and licensing government-owned inventions and technologies for commercialization.

Tetraphase Pharmaceuticals Ireland Ltd. is an Irish private company located in Dublin that manufactures basic pharmaceutical products.

LF Athens Capital LLC is a private equity fund that operates in an undisclosed location. The CEO of the American company is Michael G. Layman.

Vitranu, Inc. develops capsule technology to provide vision therapeutics solutions. The company is based in Columbus, OH. The CEO of the company is Gordon Bethwaite.

Armatus Bio, Inc. is a biotechnology company that operates at the intersection of genetic science and bioengineering. The company is based in Columbus, OH. The company was founded by Peter G. Kleinhenz, Michael Triplett. Michael Triplett has been the CEO since incorporation.

Swift Biosciences, Inc. develops molecular biology reagents. It offers Next Generation Sequencing sample preparation for Illumina and Ion Torrent platforms. The firm?s products include Accel-NGS and Amplicon Panels and myT Primer. The company was founded by David C. Olson and Vladimir L. Makarov in February 2010 and is headquartered in Ann Arbor, MI.